R. Garman

The Alzheimer's Disease Assessment Scale: Evaluation of Psychometric Properties and Patterns of Cognitive Decline in Multicenter Clinical Trials of Mild to Moderate Alzheimer's Disease

P. Doraiswamy, L. Kaiser, F. Bieber, 2001, Alzheimer disease and associated disorders.

Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer’s disease and frontotemporal lobar degeneration

G. Riedel, C. Harrington, K. Stamer, 2014, Cellular and Molecular Life Sciences.